They already have a large family by any standards, but it appears that Angelina Jolie and Brad Pitt will be adding to their brood of six children as they reportedly finalize plans to adopt a Syrian orphan.
RadarOnline have claimed that the pair decided to adopt a Syrian child after Jolie met three Syrian orphans on a solo trip as part of her role as UN Special Envoy for United Nations High Commissioner for Refugees, a position she earned after more than a decade of service as a Goodwill Ambassador.
The RadarOnline source spoke about Jolie's meeting with the three young boys:
The middle child could speak some English. The oldest of the three was very quiet but never left Angie's side during the visit. Angelina was heartbroken to learn the three of them had seen their father taken away by Syrian soldiers and their home was also bombed. And they lost their mother in the bombing.
Syria has been in a state of civil war since 2011, with the UN Refugee Agency estimating that over four million Syrians have fled to neighboring countries, and even further to get to safety.
According to the source, Jolie wanted to adopt all three of the brothers, however after Brad Pitt raised concerns about how increasing their family from six to nine children might impact their other children, the two compromised by choosing to adopt one child.
Sadly for the family they now wait in limbo, as the "very long process" to adopt the orphan is under way. The source reported that "the red tape has been almost impossible at times" and that it might take "at least another four to five months before the child is brought to the United States."
Angelina Jolie and Brad Pitt are already parents to Maddox, 14, Pax, 11, Zahara, 10, Shiloh, nine and seven-year-old twins Max and Vivienne. The eldest Jolie-Pitt children were also adopted at young ages, while the younger three are the couples biological children. Jolie is unable to have any more biological children, following a preventative oophorectomy after a test indicated possible signs of early ovarian cancer.